Best Supplements for Longevity UK: Healthy Ageing Guide

By Will  •  Posted on August 3, 2026  •  18 minutes  • 3628 words

About the author...

Will founded Supermushrooms after digging into the research behind mushroom and nootropic supplements. Every pick is checked against clinical dosing, extract standardisation, and real buyer reviews, and each star rating starts from a product's real Amazon score before being adjusted for formulation quality. Read more about how ratings are calculated.

No supplement has been shown to extend human lifespan, but NMN, CoQ10, and Omega-3 have the strongest evidence for supporting specific markers of healthy ageing, cellular energy, cardiovascular health, and cognitive resilience, with Reishi, Chaga, and Turkey Tail offering additional immune and antioxidant support in later life.

Healthy life expectancy in the UK has actually fallen in recent years for people in their fifties and sixties, even as raw life expectancy has crept upward. ONS figures put healthy life expectancy at birth at 60.7 years for men and 60.9 years for women, against an overall life expectancy of 79.1 and 83.0 years respectively. That gap, roughly two decades, is the stretch of later life spent managing declining health rather than living free of it. The number of people in the UK aged 90 and over has grown by more than half since 2004, and the centenarian population has doubled. More people are reaching old age. Fewer of those extra years are healthy ones.

That gap is what "healthy ageing" supplements are actually aimed at, or should be. It's worth being precise about this from the outset: none of the six ingredients in this guide have been shown to extend human lifespan. No supplement has. What the research does support, to varying degrees, is an effect on specific biological processes that decline with age: cellular energy production, mitochondrial function, immune surveillance, oxidative stress, and cardiovascular and cognitive health. Some of that evidence comes from robust human trials. Some comes from cell studies and animal models that haven't yet been confirmed in people. This guide tries to keep that distinction clear throughout rather than blur it in the interest of a tidier sales pitch.

The six ingredients covered here, NMN, CoQ10, omega-3, reishi, chaga and turkey tail, all have dedicated product review pages on this site, linked from each section. This guide focuses on the mechanism and the evidence for each one specifically in the context of ageing, closes with guidance on combining them sensibly, and ends with an FAQ addressing the questions we're asked most often about realistic expectations.

How Ageing Shows Up at the Cellular Level

Four biological processes come up repeatedly in the ageing research, and each ingredient in this guide maps onto one or more of them.

NAD+ decline. Nicotinamide adenine dinucleotide is a coenzyme required for hundreds of metabolic reactions, including DNA repair and mitochondrial energy production. NAD+ levels measurably fall with age in human tissue, and this decline is one of the more consistent biomarker findings in ageing biology. NMN is a direct precursor the body converts into NAD+.

Mitochondrial dysfunction. Mitochondria become less efficient at producing ATP as we age, and this decline accelerates further in anyone taking a statin, since statins block a pathway that also produces CoQ10. CoQ10 sits directly in the mitochondrial electron transport chain.

Oxidative stress and immunosenescence. Free radical damage accumulates over a lifetime, and immune function itself weakens with age, a process called immunosenescence that leaves older adults more vulnerable to infection and slower to respond to vaccination. Reishi, chaga and turkey tail all intersect with this territory, though through different mechanisms and with different strength of human evidence.

Cardiovascular and neuroinflammatory ageing. Vascular stiffening and low-grade neuroinflammation both track with age and both contribute to the two leading causes of age-related disability: cardiovascular disease and cognitive decline. Omega-3 fatty acids have the deepest and most consistent evidence base of anything in this guide for addressing this pathway.

NMN — Replenishing Cellular NAD+

Nicotinamide mononucleotide is a naturally occurring molecule that the body converts into NAD+ through a short enzymatic pathway. The appeal for healthy ageing is straightforward: NAD+ availability falls with age, and NAD+ is required for sirtuin activity, DNA repair enzymes, and mitochondrial energy metabolism, all processes with an obvious connection to how tissues age.

Human trial data on NMN has grown substantially in the last few years, and the picture is more nuanced than the marketing around it. A randomised, placebo-controlled trial in healthy, middle-aged Japanese men found that long-term NMN supplementation reliably raised NAD+ biosynthesis markers and was well tolerated over an extended dosing period.¹ A separate systematic review of randomised controlled trials found NMN supplementation was associated with improvements in specific physical performance parameters, including measures of muscle strength and walking speed in older participants, though the authors noted the number of qualifying trials remained small and effect sizes varied considerably between studies.²

What hasn't been shown is that raising NAD+ with NMN translates into a longer life, or even reliably into feeling younger in ways beyond the specific physical performance measures tested. NAD+ elevation is a genuine, replicated finding. Downstream functional benefit is a much thinner evidence base, concentrated in a handful of trials with modest sample sizes. There's also a UK-specific wrinkle worth knowing before buying: NMN is currently classified as a novel food in Great Britain and remains under Food Standards Agency assessment rather than fully authorised, which affects how products can be marketed and, in some cases, sold. Products already on the market before the relevant cut-off dates can generally continue trading during the assessment period, but the regulatory position is worth checking rather than assuming settled. Typical doses in the trials range from 250mg to 900mg daily, and products vary considerably in purity and third-party testing, both worth checking before buying.

CoQ10 — Mitochondrial Function and Statin Depletion

Coenzyme Q10 is a fat-soluble compound that sits directly in the mitochondrial electron transport chain, the pathway that converts nutrients into usable cellular energy in the form of ATP. The body produces its own CoQ10, but production declines with age, and separately, statins reduce it further by inhibiting the same metabolic pathway (HMG-CoA reductase) that generates CoQ10 as a byproduct of cholesterol synthesis.

This matters at UK population scale. Around 5.3 million people in England were prescribed a NICE-recommended statin or ezetimibe by their GP in 2023/24 alone, the highest figure on record and continuing to rise year on year. For anyone in that group experiencing statin-associated muscle aches, a genuinely common reason for discontinuing an otherwise beneficial medication, CoQ10 has a reasonable evidence base as a supportive measure. A 2025 systematic review and meta-analysis pooling multiple randomised controlled trials in statin-treated patients with muscle symptoms found a significant reduction in symptom severity with CoQ10 supplementation, though the effect wasn't uniform across every included trial and the authors called for larger, longer studies to confirm the magnitude of benefit.³

Outside the statin-specific use case, the evidence for CoQ10 as a general anti-ageing or energy supplement in people not on statins and without a diagnosed deficiency is considerably thinner, resting more on its plausible mechanism than on strong outcome trial data. Neither the NHS nor NICE currently recommends CoQ10 supplementation as standard alongside statin therapy, and it isn't a substitute for reporting muscle symptoms to a GP, since these occasionally signal something other than simple CoQ10 depletion. Two forms are sold: ubiquinone, the oxidised and cheaper form, and ubiquinol, the reduced and more bioavailable form, generally preferred by older adults whose conversion capacity between the two forms declines with age. Typical doses range from 100mg to 200mg daily.

Omega-3 — Cardiovascular and Cognitive Ageing

Omega-3 fatty acids, specifically EPA and DHA, have the longest track record and broadest evidence base of anything covered in this guide, spanning cardiovascular outcomes, inflammation, and cognitive function. The NHS Eatwell Guide recommends at least two portions of fish a week, one of them oily, specifically for the omega-3 content, which gives some sense of how mainstream this recommendation already is well outside the supplement industry.

The cognitive ageing evidence is the part most relevant to this guide and also the part that requires the most care in interpretation, because it's genuinely mixed rather than uniformly positive. An older meta-analysis of randomised controlled trials found omega-3 supplementation was associated with a reduced rate of cognitive decline in elderly populations across pooled trial data.⁴ But individual trials disagree with each other more than that pooled result suggests: some well-conducted studies in cognitively healthy older adults over multi-year follow-up periods have found no significant difference between omega-3 supplementation and placebo on cognitive outcomes, while others in populations with early cognitive impairment have found more encouraging signal, particularly for DHA and hippocampal volume. The honest summary is that omega-3 supplementation looks more useful for people starting from lower baseline intake or early-stage cognitive changes than as a guaranteed cognitive enhancer for everyone regardless of existing status.

The cardiovascular case is more established, with omega-3's triglyceride-lowering effect in particular well replicated across decades of trials, which matters directly for ageing given that cardiovascular disease remains a leading cause of disability and death in older UK adults. When buying, prioritise combined EPA and DHA content over total fish oil weight, since a bottle can list a large total oil amount while containing comparatively little of the two fatty acids that actually matter. Algae-derived omega-3 is a reasonable option for vegetarians, vegans or anyone avoiding fish oil, though DHA content tends to run lower than in fish-derived products gram for gram.

Reishi — Immune Resilience and Antioxidant Support

Reishi (Ganoderma lucidum) is one of the more heavily studied medicinal mushrooms for immune function, largely due to its beta-glucan and triterpene content. The relevance to ageing sits with immunosenescence, the age-related decline in immune surveillance that leaves older adults more vulnerable to infection and slower to mount an effective vaccine response.

A randomised, double-blind, placebo-controlled trial in healthy adult volunteers found that daily reishi beta-glucan supplementation over 84 days produced significant increases in several immune cell populations, including CD3+, CD4+ and CD8+ T-lymphocytes and natural killer cells, along with an improved CD4 to CD8 ratio compared with placebo.⁵ This is a genuinely useful data point because it's a trial in healthy humans rather than a cell culture or animal model, and immune cell counts and ratios are reasonably objective, measurable outcomes rather than subjective symptom scores.

What this trial doesn't establish is whether those improved immune cell counts translate into fewer infections, better vaccine response, or any other clinically meaningful outcome in older adults specifically, since the study population was general healthy adults rather than an ageing cohort. The triterpene content in reishi is also credited with antioxidant and mild adaptogenic effects, though this side of the evidence base leans more heavily on preclinical research than the beta-glucan immune data. Reishi is typically sold as a dual-extract (hot water and alcohol) to capture both the polysaccharide and triterpene fractions, and this is worth checking on the label, since water-only extracts miss the triterpene component entirely.

Chaga — Oxidative Stress and Cellular Senescence

Chaga (Inonotus obliquus) is consistently ranked among the highest antioxidant-content fungi tested, largely due to its polyphenol and melanin content. The ageing-relevant angle is oxidative stress, the accumulation of free radical damage to cells over time, which is one of the more established mechanistic contributors to cellular ageing across multiple tissue types.

The strongest human-relevant evidence for chaga comes from studies using human cell lines rather than whole-body clinical trials, and it's important to be direct about that distinction rather than blur it. Research using human fibroblasts found that Inonotus obliquus extract protected cells against hydrogen peroxide-induced oxidative damage and reduced markers of premature cellular senescence, effectively slowing the rate at which the cells aged in culture.⁶ That's a meaningful finding at the cellular level and consistent with chaga's broader antioxidant profile, but it was conducted in isolated human cells rather than in living study participants, and no equivalent whole-body randomised controlled trial in humans currently exists to confirm the same protective effect occurs systemically.

Practically, this means chaga is best understood as a plausible, mechanistically grounded antioxidant supplement rather than one with the same tier of clinical trial support as reishi's immune data or omega-3's cardiovascular data. It's reasonable to include as part of a broader antioxidant-supporting diet and supplement approach, without expecting a single measurable ageing outcome to shift as a result. Chaga is sold as capsules, powder and extract; look for products specifying a standardised polysaccharide or polyphenol content rather than generic "chaga powder" with no quantified active compound.

Turkey Tail — Immune Surveillance in Later Life

Turkey tail (Trametes versicolor) has one of the more clinically developed evidence bases among medicinal mushrooms, largely because its polysaccharide compounds (PSK and PSP) have been studied as an adjunct cancer therapy in Japan for decades, which has generated a body of human trial data that most other mushrooms simply don't have.

A Phase 1 clinical trial in women with breast cancer found that daily turkey tail mycelium supplementation, at doses of 6 to 9 grams, was associated with increased recovery of lymphocyte counts following chemotherapy and increased markers of natural killer cell activity, alongside good tolerability at the doses tested.⁷ This is a clinical population rather than a healthy ageing cohort, and the trial was designed around immune recovery after cancer treatment rather than general immunosenescence, so the findings shouldn't be read as directly transferable to healthy older adults taking turkey tail preventively. But the underlying mechanism, supporting lymphocyte and NK cell activity, is directly relevant to the immune decline that accompanies normal ageing, which is why turkey tail sits alongside reishi in this guide rather than being reserved only for oncology contexts.

For general healthy ageing use rather than adjunct cancer support, turkey tail is typically taken as a hot-water extract standardised to a stated polysaccharide percentage, at considerably lower doses than the clinical trial figures above, most consumer products sit in the 1 to 3 gram range. As with the other mushrooms in this guide, dual extraction and a stated beta-glucan or polysaccharide-K content are the main quality markers to look for on a label.

How to Combine These Supplements for Healthy Ageing

These six ingredients work through largely separate mechanisms, which means there's no strong pharmacological reason to avoid combining them, but there's also little value in taking all six at once without a clear reason. A more sensible approach is to identify which of the four mechanisms above is most relevant to your own situation, on a statin with muscle symptoms, concerned about cognitive ageing, recovering from frequent infections, and start there rather than assembling a maximalist stack from day one.

CoQ10 is the clearest case for a specific, targeted use: anyone on a statin experiencing muscle symptoms has a reasonably well-supported reason to trial it, ideally after discussing persistent muscle symptoms with a GP first to rule out other causes. Omega-3 is close to a universal recommendation given its cardiovascular evidence base and the fact that UK dietary oily fish intake generally falls short of the NHS-recommended two portions a week, so it earns a place in most healthy ageing approaches regardless of which other ingredients are chosen. NMN and the three mushrooms are better viewed as more targeted additions, NMN for those specifically interested in the NAD+ and cellular energy angle, and reishi or turkey tail for those with a particular interest in immune resilience, rather than default inclusions.

There are no known significant interactions between these six when taken together at standard doses, though anyone on prescribed anticoagulant or antiplatelet medication should discuss omega-3 with a GP or pharmacist first, since high-dose fish oil can mildly affect clotting, and anyone on immunosuppressant medication following organ transplant or for an autoimmune condition should be cautious with immune-modulating mushrooms like reishi and turkey tail for the same reason, working against rather than alongside the medication's intended effect. As with any supplement regime, six to twelve weeks is a reasonable minimum trial period before assessing whether a particular ingredient is doing anything noticeable, and blood-based biomarkers (lipid panel, inflammatory markers) are a more objective way to track change than subjective "feeling younger" assessments, which are prone to placebo effects in this category more than most.

What the Evidence Doesn't Yet Show

It's worth stating plainly what this guide is not claiming. None of the six ingredients above have been shown in a controlled human trial to extend lifespan, and given how long a genuine human longevity trial would need to run to demonstrate that directly, it's unlikely any single-ingredient supplement will have that evidence within the foreseeable future. What exists instead is a mix of biomarker data (NAD+ levels, immune cell counts, triglycerides), physical performance measures, and, for chaga in particular, cell-culture findings that haven't yet been tested in whole-body human trials.

That's a meaningfully different evidence tier from a drug proven to extend healthy lifespan, and it's worth treating longevity supplement marketing with the same scepticism you'd apply to any product claiming to slow ageing, a claim that is, by definition, extremely difficult to prove within a normal product development timeline. The most defensible framing for all six ingredients in this guide is as support for specific, measurable biological processes that decline with age, not as a verified route to living longer.

FAQ

Does NMN actually raise NAD+ levels in the body, and does that mean it slows ageing?

Yes to the first part, not established for the second. A placebo-controlled trial in healthy middle-aged men found long-term NMN supplementation reliably increased NAD+ biosynthesis markers,¹ and a systematic review found associated improvements in specific physical performance measures in some trials.² Whether raising NAD+ this way slows the ageing process itself, rather than affecting these specific measured outcomes, hasn't been demonstrated.

Should everyone taking a statin also take CoQ10?

Not automatically. CoQ10 has reasonable trial support specifically for people experiencing statin-associated muscle symptoms,³ but neither the NHS nor NICE recommends it as a routine addition for all statin users regardless of symptoms. Anyone with persistent muscle aches on a statin should raise it with their GP before assuming CoQ10 is the explanation.

Can omega-3 supplements slow cognitive decline in later life?

The evidence is genuinely mixed rather than settled. Pooled trial data has found a reduced rate of cognitive decline associated with omega-3 supplementation in elderly populations,⁴ but individual well-conducted trials in cognitively healthy older adults have sometimes found no significant benefit over placebo. It appears more likely to help those starting from lower baseline omega-3 intake or early cognitive changes than to act as a universal cognitive enhancer.

Do reishi and turkey tail actually change immune function, or is that just marketing?

There is genuine human trial data behind both, though of different kinds. A randomised controlled trial in healthy adults found reishi beta-glucan supplementation significantly increased several immune cell populations over an 84-day period.⁵ Turkey tail's data comes mainly from a clinical population: a Phase 1 trial in women with breast cancer found it supported lymphocyte recovery and NK cell activity following chemotherapy.⁷ Neither trial specifically studied older adults, so the immunosenescence-specific benefit is inferred from mechanism rather than directly demonstrated in an ageing cohort.

Is chaga's antioxidant effect proven in humans, or only in a lab?

Mostly the latter so far. The clearest relevant finding used human fibroblast cells in culture, showing that chaga extract protected against oxidative damage and reduced markers of premature cellular senescence.⁶ That's a genuine human-cell result, but no whole-body randomised controlled trial has yet confirmed the same protective effect occurs systemically in living study participants.

Is there any supplement that's actually been proven to extend human lifespan?

No. None of the ingredients in this guide, or any commercially available supplement, has been shown in a controlled human trial to extend lifespan, and a trial capable of proving that directly would need to run for decades. The evidence that exists is limited to specific biomarkers and functional measures, which is a genuinely different and much narrower claim than "extends life."

Conclusion

Healthy ageing supplementation is better approached as a set of targeted interventions than a single stack. Omega-3 has the broadest and most established evidence base of the six, spanning cardiovascular and, with more caveats, cognitive outcomes, and is a reasonable inclusion for most people regardless of what else they take. CoQ10 earns its place specifically for statin users with muscle symptoms rather than as a general energy supplement. NMN's NAD+-raising effect is well replicated, but the leap from that biomarker to a longer or measurably healthier life remains unproven. Reishi has the most direct human immune trial data among the three mushrooms, turkey tail's evidence leans on clinical rather than healthy-ageing populations, and chaga's strongest results are still confined to human cells in culture rather than whole-body trials.

None of that makes these six ingredients not worth taking. It does mean choosing based on which specific mechanism matches your situation, tracking objective markers where possible, and being sceptical of any product or article, including this one, that implies more certainty about lifespan extension than the current evidence actually supports.